To include your compound in the COVID-19 Resource Center, submit it here.

Furen gets rights to AZD0364 from AstraZeneca

Shanghai Furen Medicine R&D Co. Ltd. (Shanghai, China)

Read the full 88 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE